secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lucira Health, Inc. (—)
CIK:        0001652724
Form:       8-K
Filed at:   2023-04-24T23:59:59+00:00
Accession:  0001193125-23-112839
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 1.01, 2.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lucira Health sells substantially all assets to Pfizer for ~$36.4M in bankruptcy
--------------------------------------------------------------------------------

- Asset sale closed April 20, 2023, after Chapter 11 court approval on April 19.
- Total consideration ~$36.4M: $5M cash, cure costs, plus additional payments up to $10.4M.
- Amendment increased base consideration by $10.4M and fixed Jabil cure costs at $6.5M.
- Company had $132.8M federal and $81.6M state NOLs as of April 1, 2023.
- Pfizer won Section 363 auction on April 6, 2023; sale includes substantially all assets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652724/000119312523112839/0001193125-23-112839-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652724/000119312523112839/d446319d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-112839

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer